Epigenetic Alterations in Acute Kidney Injury

被引:36
作者
Bomsztyk, Karol [1 ]
Denisenko, Oleg [1 ]
机构
[1] Univ Washington, Univ Washington Med Lake Union, Dept Med, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
Epigenetics; acute kidney injury; chromatin; histone modification; DNA methylation; RNA-POLYMERASE-II; DNA METHYLATION; HISTONE MODIFICATIONS; CHROMATIN MODIFICATIONS; SET2; METHYLATION; TRANSCRIPTION; ENDOTOXIN; CURCUMIN; GENES; PROTECTS;
D O I
10.1016/j.semnephrol.2013.05.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Acute kidney injury (AKI) is a risk factor for chronic kidney disease and death. Despite progress made in understanding the cellular and molecular basis of AKI pathogenesis there has been no improvement in the high mortality rate from this disease in decades. Epigenetics is one of the most intensively studied fields of biology today and represents a new paradigm for understanding the pathophysiology of disease. Although epigenetics of AKI is a nascent field, the available information already is providing compelling evidence that chromatin biology plays a critical role in this disease. In this article we explore what is known about the contribution of epigenetic mechanisms to the pathophysiology of AKI and how this knowledge already is guiding the development of new diagnostic tools and epigenetic therapies. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 106 条
  • [1] Mediators of Inflammation in Acute Kidney Injury
    Akcay, Ali
    Nguyen, Quocan
    Edelstein, Charles L.
    [J]. MEDIATORS OF INFLAMMATION, 2009, 2009
  • [2] New nomenclature for chromatin-modifying enzymes
    Allis, C. David
    Berger, Shelley L.
    Cote, Jacques
    Dent, Sharon
    Jenuwien, Thomas
    Kouzarides, Tony
    Pillus, Lorraine
    Reinberg, Danny
    Shi, Yang
    Shiekhattar, Ramin
    Shilatifard, Ali
    Workman, Jerry
    Zhang, Yi
    [J]. CELL, 2007, 131 (04) : 633 - 636
  • [3] Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
    Azmi, Asfar S.
    Wang, Zhiwei
    Philip, Philip A.
    Mohammad, Ramzi M.
    Sarkar, Fazlul H.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (12) : 3137 - 3144
  • [4] Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription
    Balasubramanyam, K
    Varier, RA
    Altaf, M
    Swaminathan, V
    Siddappa, NB
    Ranga, U
    Kundu, TK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) : 51163 - 51171
  • [5] A Peek into the Complex Realm of Histone Phosphorylation
    Banerjee, Taraswi
    Chakravarti, Debabrata
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (24) : 4858 - 4873
  • [6] High-resolution profiling of histone methylations in the human genome
    Barski, Artern
    Cuddapah, Suresh
    Cui, Kairong
    Roh, Tae-Young
    Schones, Dustin E.
    Wang, Zhibin
    Wei, Gang
    Chepelev, Iouri
    Zhao, Keji
    [J]. CELL, 2007, 129 (04) : 823 - 837
  • [7] Curcumin protects against ischemia/reperfusion injury in rat kidneys
    Bayrak, Omer
    Uz, Ebru
    Bayrak, Reyhan
    Turgut, Faruk
    Atmaca, Ali Fuat
    Sahin, Semsettin
    Yildirim, Mehmet Erol
    Kaya, Arif
    Cimentepe, Ersin
    Akcay, Ali
    [J]. WORLD JOURNAL OF UROLOGY, 2008, 26 (03) : 285 - 291
  • [8] BET domain co-regulators in obesity, inflammation and cancer
    Belkina, Anna C.
    Denis, Gerald V.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (07) : 465 - 477
  • [9] The protein CTCF is required for the enhancer blocking activity of vertebrate insulators
    Bell, AC
    West, AG
    Felsenfeld, G
    [J]. CELL, 1999, 98 (03) : 387 - 396
  • [10] FACT facilitates transcription-dependent nucleosome alteration
    Belotserkovskaya, R
    Oh, S
    Bondarenko, VA
    Orphanides, G
    Studitsky, VM
    Reinberg, D
    [J]. SCIENCE, 2003, 301 (5636) : 1090 - 1093